| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMEA/748707/2009 (20.11.09) |
| Publication Date | 20/11/2009 |
| Content Type | News |
|
The European Medicines Agency (EMEA), on 20 November 2009, announced that it had reviewed further data on the centrally authorised pandemic vaccines, Celvapan, Focetria and Pandemrix. The Agency reaffirmed their positive balance of benefits and risks in the context of the current H1N1 influenza pandemic. |
|
| Source Link | Link to Main Source http://www.emea.europa.eu/pdfs/human/press/pr/74870709en.pdf |
| Subject Categories | Health |
| Countries / Regions | Europe |
